DEF 14AThe Ballot
Gain Therapeutics, Inc. files DEF 14A
Filed May 13, 2022 · 4y ago · Accession 0001104659-22-060288
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Gain Therapeutics, Inc.
- Ticker
- GANX
- CIK
- 1819411
- Form type
- DEF 14A
- Filing date
- May 13, 2022
- Report date
- Jun 16, 2022
- Document
- tm2215140-1_def14a.htm
- Size
- 2.5 MB